Serial measurement of serum C-reactive protein levels can identify patients at risk for severe complications following autologous stem cell transplantation.
The value of serum C-reactive protein (CRP) levels as a predictor of complications in neutropenic patients needs to be further defined. We sought to identify an association between severe complications and daily CRP levels measured in 104 multiple myeloma patients during the 3 week period following high-dose melphalan and autologous transplant. Significantly higher mean CRP levels and CRP velocity of increase were observed among patients with severe complications. A cut-off point of 100 mg/l (CRP levels) and 15 mg/l/day (CRP velocity) identified patients likely to suffer severe complications with 86 and 75% sensitivity, respectively. Prospective validation of this model is currently underway.
Fassas
A B-T
AB
Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA. FassasAthanasios@uams.edu
Miceli
M H
MH
Grazzlutti
M
M
Dong
L
L
Barlogie
B
B
Anaissie
E
E
D002097:C-Reactive Protein / Q000032:analysis / Q000378:metabolism*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D009101:Multiple Myeloma / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D011446:Prospective Studies; D012044:Regression Analysis; D012189:Retrospective Studies; D012307:Risk Factors; D012680:Sensitivity and Specificity
D002097:C-Reactive Protein